Publications by authors named "Tracey Otto"

Claim this Profile
H
Hidradenitis Suppurativa: New Targets and Emerging Treatments.
Julia L Gao, Tracey S Otto, Martina L Porter, Alexa B Kimball

Am J Clin Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Psoriasis Therapies.
JaBreia James, Tracey Otto, Julia Gao, Martina L Porter

Dermatol Clin· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pearl for Pretibial and Forearm Repair Following Mohs Micrographic Surgery.
Tracey S Otto, Sara D Ragi, Ann M John, Hamza Bhatti

J Drugs Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation.
Ted V Jacoby, Maria S Asdourian, Nishi Shah, Tracey S Otto, Leah L Thompson

Clin Exp Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management.
Rohan Mital, Tracey S Otto, Andrei Savu, Emily Baumrin, Adela R Cardones

Int J Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
Michael R Stephens, Maria S Asdourian, Ted V Jacoby, Nishi Shah, Leah L Thompson, Tracey Otto

J Am Acad Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy.
Maria S Asdourian, Ted V Jacoby, Nishi Shah, Tracey Otto, Leah L Thompson

J Am Acad Dermatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition.
Ted V Jacoby, Nishi Shah, Maria S Asdourian, Leah L Thompson, Tracey S Otto

J Am Acad Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study.
Maria S Asdourian, Ted V Jacoby, Nishi Shah, Leah L Thompson, Tracey Otto

J Am Acad Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade.
Maria S Asdourian, Nishi Shah, Ted V Jacoby, Yevgeniy R Semenov, Tracey Otto

J Am Acad Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy.
Maria S Asdourian, Nishi Shah, Ted V Jacoby, Leah L Thompson, Tracey Otto

J Am Acad Dermatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
Maria S Asdourian, Tracey S Otto, Ted V Jacoby, Nishi Shah, Leah L Thompson

J Am Acad Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of pre-existing drug allergies with cutaneous immune-related adverse events among patients on immune checkpoint inhibitor therapy.
Ted V Jacoby, Tracey S Otto, Maria S Asdourian, Nishi Shah, Mara Farcasanu

Br J Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the treatment of cutaneous adverse events and adherence to National Comprehensive Cancer Network guidelines in patients receiving immune checkpoint inhibitors.
Michael S Chang, Ted V Jacoby, Tracey S Otto, Nishi Shah, Maria S Asdourian

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Study of Idiopathic Granulomatous Mastitis Treatment and Outcomes.
Tracey Otto, Yahya Argobi, Gideon Smith, Flavia Fedeles

J Drugs Dermatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of idiopathic granulomatous mastitis diagnosis and clinical presentation.
Tracey S Otto, Yahya Argobi, Melinda J Lerwill, Gideon P Smith, Flavia Fedeles

J Am Acad Dermatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction.
Eli T Sayegh, Tracey S Otto, Kirsten D Garvey, Anna Martin, Natalie A Lowenstein

J Am Acad Orthop Surg Glob Res Rev· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid.
Connie R Shi, Tracey S Otto, Leah L Thompson, Michael S Chang, Kerry L Reynolds

Eur J Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.
Briana Rose Halle, Allison Betof Warner, Farzana Y Zaman, Andrew Haydon, Prachi Bhave, Tracey S Otto

J Immunother Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatology's dearth of diversity: Considerations in providing support to students underrepresented in medicine at home and away.
Tracey S Otto, Sacharitha Bowers, Steven T Chen

Int J Womens Dermatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: "Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions".
Gabriel E Molina, Tracey S Otto, Zizi Yu, Ruth K Foreman, Kerry L Reynolds

J Am Acad Dermatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limitations of morphology-based management for immune checkpoint inhibitor-related cutaneous adverse events.
Tracey S Otto, Michael S Chang, Leah L Thompson, Steven T Chen

J Am Acad Dermatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis